66 results
Page 3 of 4
D
xp6chplvwx8iw6ahkdu7
26 Oct 21
$5.92M in options / securities to be acquired, 10 investors
1:39pm
8-K
EX-10.1
93jf6
15 Oct 21
Petros Pharmaceuticals Announces $5.7 Million Registered Direct Offering
5:03pm
424B5
9ck2vc6r2 sv3pib
15 Oct 21
Prospectus supplement for primary offering
5:01pm
10-Q
f9ud ue32ge
14 May 21
Quarterly report
4:31pm
10-K
EX-10.9
ce6xsl83
31 Mar 21
Annual report
4:30pm
10-K
hpktne7 5ednzsg8b
31 Mar 21
Annual report
4:30pm
10-K
EX-10.1
7ykbi0gnv2nekdw
31 Mar 21
Annual report
4:30pm
8-K
EX-10.1
yusq5g iai8p
25 Feb 21
Departure of Directors or Certain Officers
4:15pm
S-3
EX-4.3
gbzaped55qm
29 Jan 21
Shelf registration
4:48pm
S-3
EX-4.4
kdpn7 i8ovdcxh5h3vzw
29 Jan 21
Shelf registration
4:48pm
S-3
gdwxcwhwf
29 Jan 21
Shelf registration
4:48pm
8-K/A
EX-99.1
mocumgqv
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K/A
EX-10.1
6drvtzcegz0vqm7
31 Dec 20
Metuchen’s Management’s Discussion and Analysis of Financial Condition and Results of Operations
5:00pm
8-K
EX-3.1
h0sjb wfxbp1un75
2 Dec 20
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals
9:14am
424B3
o2tq2ray9lsd5ohw9z5
2 Nov 20
Prospectus supplement
12:00am